Citation: | TAO Dan, GONG Wei, QIN Songbing, XU Xiaoting, ZHOU Juying, WANG Lili. Value of perioperative carcinoembryonic antigen combined with carbohydrate antigen 19-9 and carbohydrate antigen 125 in predicting prognosis of patients with colorectal cancer in stages Ⅰ to Ⅲ[J]. Journal of Clinical Medicine in Practice, 2021, 25(9): 46-51. DOI: 10.7619/jcmp.20210560 |
[1] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
|
[2] |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005
|
[3] |
STRACCI F, ZORZI M, GRAZZINI G. Colorectal cancer screening: tests, strategies, and perspectives[J]. Front Public Health, 2014, 2: 210. http://europepmc.org/articles/PMC4209818
|
[4] |
SAITO G, SADAHIRO S, KAMATA H, et al. Monitoring of serum carcinoembryonic antigen levels after curative resection of colon cancer: cutoff values determined according to preoperative levels enhance the diagnostic accuracy for recurrence[J]. Oncology, 2017, 92(5): 276-282. doi: 10.1159/000456075
|
[5] |
RAMPHAL W, BOEDING J R E, VAN IWAARDEN M, et al. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer[J]. Int J Biol Markers, 2019, 34(1): 60-68. doi: 10.1177/1724600818820679
|
[6] |
LIN P C, LIN J K, LIN C C, et al. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis[J]. Int J Colorectal Dis, 2012, 27(10): 1333-1338. doi: 10.1007/s00384-012-1447-1
|
[7] |
LI Q, DAI W, LI Y, et al. Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection[J]. Sci Rep, 2017, 7: 46345. doi: 10.1038/srep46345
|
[8] |
ZHONG W, YU Z, ZHAN J, et al. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer[J]. Pathol Oncol Res, 2015, 21(1): 83-95. doi: 10.1007/s12253-014-9791-9
|
[9] |
GUNAWARDENE A, LARSEN P, SHEKOUH A, et al. Pre-operative carcinoembryonic antigen predicts survival following colorectal cancer surgery with curative intent[J]. ANZ J Surg, 2018, 88(12): 1311-1315. doi: 10.1111/ans.14723
|
[10] |
BHATTI I, PATEL M, DENNISON A R, et al. Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer[J]. Int J Surg, 2015, 16(Pt A): 123-128. http://www.ncbi.nlm.nih.gov/pubmed/25771102
|
[11] |
SØRENSEN C G, KARLSSON W K, POMMERGAARD H C, et al. The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence-A systematic review[J]. Int J Surg, 2016, 25: 134-144. http://www.sciencedirect.com/science/article/pii/S1743919115013953
|
[12] |
LIN J K, LIN C C, YANG S H, et al. Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer[J]. Int J Colorectal Dis, 2011, 26(9): 1135-1141. doi: 10.1007/s00384-011-1209-5
|
[13] |
KONISHI T, SHIMADA Y, HSU M, et al. Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome[J]. JAMA Oncol, 2018, 4(3): 309-315. doi: 10.1001/jamaoncol.2017.4420
|
[14] |
SHIBUTANI M, MAEDA K, NAGAHARA H, et al. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage Ⅱ colorectal cancer[J]. Anticancer Res, 2014, 34(7): 3753-3758. http://europepmc.org/abstract/MED/24982398
|
[15] |
USHIGOME M, SHIMADA H, MIURA Y, et al. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA[J]. Int J Clin Oncol, 2020, 25(4): 622-632. doi: 10.1007/s10147-019-01597-6
|
[16] |
SCARÁS, BOTTONI P, SCATENA R. CA 19-9: biochemical and clinical aspects[J]. Adv Exp Med Biol, 2015, 867: 247-260. doi: 10.1007/978-94-017-7215-0_15
|
[17] |
ZHOU W H, YANG F, PENG J H, et al. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage Ⅲcolon cancer after curative resection and adjuvant chemotherapy[J]. J Cancer, 2019, 10(16): 3810-3818. doi: 10.7150/jca.31375
|
[18] |
TOKODAI K, NARIMATSU H, NISHIDA A, et al. Risk factors for recurrence in stage Ⅱ/Ⅲcolorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern[J]. J Surg Oncol, 2016, 114(3): 368-374. doi: 10.1002/jso.24320
|
[19] |
YANG X Q, LI Y, CHEN C, et al. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer[J]. Med Oncol, 2011, 28(3): 789-795. doi: 10.1007/s12032-010-9518-z
|
[20] |
HUANG S H, TSAI W S, YOU J F, et al. Preoperative carcinoembryonic antigen as a poor prognostic factor in stage Ⅰ~Ⅲcolorectal cancer after curative-intent resection: a propensity score matching analysis[J]. Ann Surg Oncol, 2019, 26(6): 1685-1694. doi: 10.1245/s10434-019-07184-3
|
[21] |
HOTTA T, TAKIFUJI K, YOKOYAMA S, et al. Impact of the post/preoperative serum CEA ratio on the survival of patients with rectal cancer[J]. Surg Today, 2014, 44(11): 2106-2115. doi: 10.1007/s00595-014-0852-1
|